Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-02
1985-06-04
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514412, 546 17, 546216, 546221, 546208, 548409, C07D491113, A61K 31455
Patent
active
045215375
ABSTRACT:
Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds of the formula ##STR1## where the substituents are as defined herein, are useful in the treatment of hypertension in mammals. Such compounds, their use as antihypertensive agents, pharmaceutical compositions containing the compounds, intermediates and processes for preparing the compounds are provided.
REFERENCES:
patent: 3679666 (1972-07-01), Maiatestinic et al.
patent: 4405631 (1983-09-01), Kosley et al.
Cherill Robert J.
Kosley, Jr. Raymond W.
Bond Robert T.
Hoechst-Roussel Pharmaceuticals Incorporated
LandOfFree
Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-829317